Elanco Animal Health Incorporated (FRA:5EA)

Elanco Animal Health Statistics

Total Valuation

FRA:5EA has a market cap or net worth of EUR 10.03 billion. The enterprise value is 13.31 billion.

Market Cap	10.03B
Enterprise Value	13.31B

Important Dates

The next estimated earnings date is Tuesday, February 24, 2026.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	496.86M
Shares Outstanding	n/a
Shares Change (YoY)	+0.93%
Shares Change (QoQ)	-0.66%
Owned by Insiders (%)	0.70%
Owned by Institutions (%)	115.46%
Float	492.88M

Valuation Ratios

The trailing PE ratio is 326.74 and the forward PE ratio is 24.32.

PE Ratio	326.74
Forward PE	24.32
PS Ratio	2.56
PB Ratio	1.74
P/TBV Ratio	n/a
P/FCF Ratio	31.96
P/OCF Ratio	18.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.52, with an EV/FCF ratio of 42.43.

EV / Earnings	433.74
EV / Sales	3.37
EV / EBITDA	16.52
EV / EBIT	62.67
EV / FCF	42.43

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.64.

Current Ratio	2.40
Quick Ratio	1.02
Debt / Equity	0.64
Debt / EBITDA	4.61
Debt / FCF	11.75
Interest Coverage	1.33

Financial Efficiency

Return on equity (ROE) is 0.54% and return on invested capital (ROIC) is 1.41%.

Return on Equity (ROE)	0.54%
Return on Assets (ROA)	1.15%
Return on Invested Capital (ROIC)	1.41%
Return on Capital Employed (ROCE)	2.04%
Revenue Per Employee	424,164
Profits Per Employee	3,326
Employee Count	9,450
Asset Turnover	0.34
Inventory Turnover	1.24

Taxes

Income Tax	-44.32M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +64.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+64.38%
50-Day Moving Average	13.81
200-Day Moving Average	13.54
Relative Strength Index (RSI)	67.13
Average Volume (20 Days)	901

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.88

Income Statement

In the last 12 months, FRA:5EA had revenue of EUR 3.91 billion and earned 30.68 million in profits. Earnings per share was 0.06.

Revenue	3.91B
Gross Profit	2.15B
Operating Income	210.52M
Pretax Income	-13.64M
Net Income	30.68M
EBITDA	751.73M
EBIT	210.52M
Earnings Per Share (EPS)	0.06

Balance Sheet

The company has 430.41 million in cash and 3.69 billion in debt, with a net cash position of -3.25 billion.

Cash & Cash Equivalents	430.41M
Total Debt	3.69B
Net Cash	-3.25B
Net Cash Per Share	n/a
Equity (Book Value)	5.75B
Book Value Per Share	11.58
Working Capital	1.74B

Cash Flow

In the last 12 months, operating cash flow was 536.10 million and capital expenditures -222.45 million, giving a free cash flow of 313.65 million.

Operating Cash Flow	536.10M
Capital Expenditures	-222.45M
Free Cash Flow	313.65M
FCF Per Share	n/a

Margins

Gross margin is 54.96%, with operating and profit margins of 5.38% and 0.78%.

Gross Margin	54.96%
Operating Margin	5.38%
Pretax Margin	-0.35%
Profit Margin	0.78%
EBITDA Margin	19.21%
EBIT Margin	5.38%
FCF Margin	8.02%

Dividends & Yields

FRA:5EA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.93%
Shareholder Yield	-0.93%
Earnings Yield	0.31%
FCF Yield	3.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:5EA has an Altman Z-Score of 0.96 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.96
Piotroski F-Score	7